These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32463481)

  • 21. Gut Microbiome and Response to Cardiovascular Drugs.
    Tuteja S; Ferguson JF
    Circ Genom Precis Med; 2019 Sep; 12(9):421-429. PubMed ID: 31462078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of gut microbiota in the pharmacokinetics of antihypertensive drugs.
    Choi MS; Yu JS; Yoo HH; Kim DH
    Pharmacol Res; 2018 Apr; 130():164-171. PubMed ID: 29391236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.
    Enright EF; Griffin BT; Gahan CGM; Joyce SA
    Pharmacol Res; 2018 Jul; 133():170-186. PubMed ID: 29660405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota-Mediated Drug-Antibiotic Interactions.
    Kim DH
    Drug Metab Dispos; 2015 Oct; 43(10):1581-9. PubMed ID: 25926432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes.
    Zhang J; Zhang J; Wang R; Jia Z
    Curr Drug Metab; 2019; 20(2):155-165. PubMed ID: 30338735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bringing microbiome-drug interaction research into the clinic.
    Guthrie L; Kelly L
    EBioMedicine; 2019 Jun; 44():708-715. PubMed ID: 31151933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic effect of gut microbiota on drugs.
    Xie Y; Hu F; Xiang D; Lu H; Li W; Zhao A; Huang L; Wang R
    Drug Metab Rev; 2020 Feb; 52(1):139-156. PubMed ID: 32116054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bidirectional interactions between dietary curcumin and gut microbiota.
    Shen L; Ji HF
    Crit Rev Food Sci Nutr; 2019; 59(18):2896-2902. PubMed ID: 29781709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps.
    Sutherland VL; McQueen CA; Mendrick D; Gulezian D; Cerniglia C; Foley S; Forry S; Khare S; Liang X; Manautou JE; Tweedie D; Young H; Alekseyenko AV; Burns F; Dietert R; Wilson A; Chen C
    Toxicol Sci; 2020 Jul; 176(1):1-10. PubMed ID: 32658296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
    Prokopienko AJ; Nolin TD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):71-82. PubMed ID: 28905671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
    Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
    J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Gut Microbiota and Drug Metabolism.
    Pant A; Maiti TK; Mahajan D; Das B
    Microb Ecol; 2023 Jul; 86(1):97-111. PubMed ID: 35869999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome.
    Maldonado-Gómez MX; Martínez I; Bottacini F; O'Callaghan A; Ventura M; van Sinderen D; Hillmann B; Vangay P; Knights D; Hutkins RW; Walter J
    Cell Host Microbe; 2016 Oct; 20(4):515-526. PubMed ID: 27693307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.